Plastic and nonmetallic article shaping or treating: processes – Forming continuous or indefinite length work – Shaping by extrusion
Reexamination Certificate
2000-09-28
2003-07-15
Tentoni, Leo B. (Department: 1732)
Plastic and nonmetallic article shaping or treating: processes
Forming continuous or indefinite length work
Shaping by extrusion
C264S17800F, C264S202000
Reexamination Certificate
active
06592794
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to a class of fiber or strand suspension compositions, including methods and apparatus for producing such compositions. The compositions may be processed further into viscoelastic pastes or porous solids. Preferred compositions of the invention comprise biologically derived or biologically compatible materials, such as collagen that can be injected or implanted for tissue augmentation or repair.
BACKGROUND OF THE INVENTION
Collagen is the principal structural protein in the body and constitutes approximately one third of the total body protein. It comprises most of the organic matter of the skin, tendons, bones and teeth and occurs as fibrous inclusions in most other body structures. Some of the properties of collagen are its high tensile strength; its ion exchanging ability, due in part to the binding of electrolytes, metabolites and drugs; its low antigenicity, due to masking of potential antigenic determinants by the helical structure, and its low extensibility, semipermeability, and solubility. Furthermore collagen is a natural substance for cell adhesion. These properties make this protein suitable for fabrication of bioremodelable research products and medical devices such as implantable prostheses, cell growth substrates, and cellular and acellular tissue constructs.
Collagen compositions are typically prepared from skin or tendons by dispersion, digestion or dissolution, or a combination thereof, of the native tissue collagen. Dispersion involves mechanically shearing the tissue to produce a suspension of collagen fibers. Digestion involves enzyme degradation of the non-helical telopeptide portions of the collagen molecule, resulting in a solution of atelopeptide collagen. Dissolution involves cleavage of acid labile crosslinks in newly formed collagen fibers resulting in a solution of collagen monomers and polymers using procedures involving acid or enzyme extraction. Enzyme extraction is preferable in many instances because its methodology produces increased yield and higher purity collagen. However enzyme extraction suffers the disadvantage of producing partially degraded collagen, i.e., the extraction enzymes cleave the collagen molecule at the terminal non-helical regions which contain the inter-molecular cross-linkages.
Injectable formulations have been used in the art as tissue bulking compositions, particularly in urology and plastic surgery. Upon implantation to a patient, however, the volume persistence of previous implants decreases partly due to the absorption of the aqueous carrier by the body and partly due to the low concentration of the collagen. Follow up or “top-off” injections at the site are usually necessary with previously developed collagen compositions because the volume decreases due to the absorption of liquid component of the composition by the body. Therefor, volume persistence and shape persistence are desired of an injectable collagen implant. Higher concentrations of collagen helps to maintain volume persistence, but at the same time decreases extrudability and intrudability of the composition through a needle and into the patient's tissue.
Besides volume persistence, shape persistence is desired of the injectable collagen compositions known in the art. When injected, the collagen tends to migrate through the tissue; therefore, if specific and local tissue augmentation or bulking is required, such migration would necessitate subsequent injections.
The present invention describes a collagen composition in the form of bioengineered collagen fibers, apparatus methods for making bioengineered collagen fibers and their use as an injectable collagen composition that overcomes the drawbacks of injectable collagen compositions known in the art. Other preferred embodiments directed to bioengineered collagen fibers formed into a matrix substrate for cell culture and a composition comprising compacted fibers for surgical implantation are also disclosed.
SUMMARY OF THE INVENTION
The invention provides bioengineered collagen fibers and injectable collagen compositions comprising bioengineered collagen fibers and apparatus and methods for making and using such bioengineered collagen fibers.
The present invention provides injectable collagen compositions having improved properties over known injectable collagen compositions in the art. Preferred injectable collagen compositions prepared in accordance to the present invention have a high concentration of collagen. The injectable compositions are useful for tissue augmentation, tissue repair and drug delivery. The bioengineered collagen fiber compositions may be used to make a matrix substrate for cell culture or a solid compacted matrix of fibers for implantation. The bioengineered collagen fiber compositions have improved characteristics for bioremodeling compared to other known compositions. compositions.
REFERENCES:
patent: 4642117 (1987-02-01), Nguyen et al.
patent: 4702876 (1987-10-01), Ebregt et al.
patent: 4703108 (1987-10-01), Silver et al.
patent: 4803075 (1989-02-01), Wallace et al.
patent: 5106949 (1992-04-01), Kemp et al.
patent: 5256418 (1993-10-01), Kemp et al.
patent: 5378469 (1995-01-01), Kemp et al.
patent: 5475052 (1995-12-01), Rhee et al.
patent: 5997896 (1999-12-01), Carr, Jr. et al.
patent: 0 284 789 (1988-10-01), None
patent: WO 94/01483 (1994-01-01), None
patent: WO 94/03119 (1994-02-01), None
patent: WO 96/40216 (1996-12-01), None
Garg et al., “Reconstituted Collagen Fibers: Effect of Proteoglycans” IEEE 1988, pp 84-87.
Kato et al., “Formulation of Continuous Collagen Fibres: Evaluation of Biocompatibility and Mechanical Properties” Biomaterials 1990, vol. 11, pp 169-175.
Kligman et al., “Histologic Response to Intradermal Zyderm and Zyplast (Glutaraldehyde Cross-Linked) Collagen in Humans” J. Dermatol. Surg. Oncol. vol. 12:4, Apr. 1986, pp 351-357.
Knapp et al., “Behavior of Solubilized Collagen as a Bioimplant” Journal of Surgical Research, vol. 23: 2, p 96-105 (1977).
Hale and Dorr LLP
Organogenesis Inc.
Tentoni Leo B.
LandOfFree
Process of making bioengineered collagen fibrils does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process of making bioengineered collagen fibrils, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process of making bioengineered collagen fibrils will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3078913